Have a feature idea you'd love to see implemented? Let us know!

PDEX Pro Dex Inc

Price (delayed)

$53.16

Market cap

$173.27M

P/E Ratio

34.3

Dividend/share

N/A

EPS

$1.55

Enterprise value

$184.73M

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. It ...

Highlights
Pro Dex's EPS has surged by 154% QoQ and by 4.7% YoY
PDEX's net income has surged by 145% since the previous quarter
PDEX's P/E is 113% above its 5-year quarterly average of 16.3 and 36% above its last 4 quarters average of 25.6
Pro Dex's debt has increased by 12% YoY and by 11% QoQ

Key stats

What are the main financial stats of PDEX
Market
Shares outstanding
3.26M
Market cap
$173.27M
Enterprise value
$184.73M
Valuations
Price to earnings (P/E)
34.3
Price to book (P/B)
5.78
Price to sales (P/S)
3.05
EV/EBIT
25.1
EV/EBITDA
21.63
EV/Sales
3.25
Earnings
Revenue
$56.8M
EBIT
$7.36M
EBITDA
$8.54M
Free cash flow
$6.41M
Per share
EPS
$1.55
Free cash flow per share
$1.97
Book value per share
$9.19
Revenue per share
$17.42
TBVPS
$16.65
Balance sheet
Total assets
$54.31M
Total liabilities
$23.43M
Debt
$14.55M
Equity
$30.88M
Working capital
$27.22M
Liquidity
Debt to equity
0.47
Current ratio
3.41
Quick ratio
1.89
Net debt/EBITDA
1.34
Margins
EBITDA margin
15%
Gross margin
28.2%
Net margin
9.2%
Operating margin
14.7%
Efficiency
Return on assets
10%
Return on equity
16.7%
Return on invested capital
14.2%
Return on capital employed
17.1%
Return on sales
13%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PDEX stock price

How has the Pro Dex stock price performed over time
Intraday
-1.23%
1 week
4.26%
1 month
30.84%
1 year
227.14%
YTD
203.42%
QTD
78.09%

Financial performance

How have Pro Dex's revenue and profit performed over time
Revenue
$56.8M
Gross profit
$16.04M
Operating income
$8.35M
Net income
$5.21M
Gross margin
28.2%
Net margin
9.2%
PDEX's net income has surged by 145% since the previous quarter
Pro Dex's net margin has surged by 130% QoQ but it has decreased by 18% YoY
PDEX's operating income is up by 26% year-on-year and by 16% since the previous quarter
PDEX's revenue is up by 21% YoY and by 5% QoQ

Growth

What is Pro Dex's growth rate over time

Valuation

What is Pro Dex stock price valuation
P/E
34.3
P/B
5.78
P/S
3.05
EV/EBIT
25.1
EV/EBITDA
21.63
EV/Sales
3.25
Pro Dex's EPS has surged by 154% QoQ and by 4.7% YoY
PDEX's P/E is 113% above its 5-year quarterly average of 16.3 and 36% above its last 4 quarters average of 25.6
PDEX's price to book (P/B) is 154% higher than its last 4 quarters average of 2.3 and 77% higher than its 5-year quarterly average of 3.3
The stock's price to sales (P/S) is 121% more than its last 4 quarters average of 1.4 and 63% more than its 5-year quarterly average of 1.9
PDEX's revenue is up by 21% YoY and by 5% QoQ

Efficiency

How efficient is Pro Dex business performance
The return on equity has surged by 146% since the previous quarter but it has declined by 10% year-on-year
Pro Dex's return on assets has surged by 138% QoQ but it has decreased by 7% YoY
Pro Dex's ROIC has soared by 129% from the previous quarter but it has decreased by 5% YoY
Pro Dex's return on sales has surged by 120% QoQ but it has decreased by 20% YoY

Dividends

What is PDEX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PDEX.

Financial health

How did Pro Dex financials performed over time
The total assets is 132% greater than the total liabilities
PDEX's total liabilities is up by 27% YoY and by 8% QoQ
Pro Dex's current ratio has increased by 20% QoQ but it has decreased by 10% YoY
Pro Dex's debt is 53% lower than its equity
Pro Dex's debt to equity has increased by 15% YoY and by 12% from the previous quarter
Pro Dex's debt has increased by 12% YoY and by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.